BRPI0810710A2 - Método para estabilização de uma proteína. - Google Patents

Método para estabilização de uma proteína.

Info

Publication number
BRPI0810710A2
BRPI0810710A2 BRPI0810710-6A2A BRPI0810710A BRPI0810710A2 BR PI0810710 A2 BRPI0810710 A2 BR PI0810710A2 BR PI0810710 A BRPI0810710 A BR PI0810710A BR PI0810710 A2 BRPI0810710 A2 BR PI0810710A2
Authority
BR
Brazil
Prior art keywords
stabilizing
protein
Prior art date
Application number
BRPI0810710-6A2A
Other languages
English (en)
Inventor
Wolfgang Friess
Sylvia Kiese
Hanns-Christian Mahler
Astrid Pappenberger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0810710A2 publication Critical patent/BRPI0810710A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0810710-6A2A 2007-05-02 2008-04-22 Método para estabilização de uma proteína. BRPI0810710A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107353 2007-05-02
PCT/EP2008/054835 WO2008135380A1 (en) 2007-05-02 2008-04-22 Method for stabilizing a protein

Publications (1)

Publication Number Publication Date
BRPI0810710A2 true BRPI0810710A2 (pt) 2014-10-21

Family

ID=39674831

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810710-6A2A BRPI0810710A2 (pt) 2007-05-02 2008-04-22 Método para estabilização de uma proteína.

Country Status (11)

Country Link
US (1) US7879976B2 (pt)
EP (1) EP2144629A1 (pt)
JP (1) JP2010524479A (pt)
KR (1) KR101140483B1 (pt)
CN (1) CN101674847A (pt)
AU (1) AU2008248780B2 (pt)
BR (1) BRPI0810710A2 (pt)
CA (1) CA2685372A1 (pt)
IL (1) IL201391A0 (pt)
MX (1) MX2009011408A (pt)
WO (1) WO2008135380A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE027134T2 (en) 2002-09-11 2016-10-28 Chugai Pharmaceutical Co Ltd Method for protein purification
EP2527364A1 (en) 2007-03-29 2012-11-28 Abbott Laboratories Crystalline anti-human IL-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
GB0913773D0 (en) * 2009-08-07 2009-09-16 Isis Innovation Assay
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
TWI606840B (zh) 2010-11-11 2017-12-01 艾伯維生物技術有限責任公司 具有增進高濃度之抗-TNFα抗體之液體調配物
US8883979B2 (en) 2012-08-31 2014-11-11 Bayer Healthcare Llc Anti-prolactin receptor antibody formulations
JP6463268B2 (ja) 2012-09-07 2019-01-30 コヒラス・バイオサイエンシズ・インコーポレイテッド 安定水性アダリムマブ製剤
AU2014298519A1 (en) * 2013-08-02 2016-02-04 F. Hoffmann-La Roche Ag Therapeutic fusion protein
JP6797137B2 (ja) 2015-05-29 2020-12-09 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Ox40に対する抗体およびその使用
IL302486A (en) 2015-06-24 2023-06-01 Hoffmann La Roche Antibodies against the transnephrine receptor with adapted affinity
AR106189A1 (es) * 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
MX2018003822A (es) 2015-10-02 2018-06-22 Hoffmann La Roche Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso.
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US11071782B2 (en) * 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace
WO2017189959A1 (en) * 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
AU2019345166B2 (en) 2018-09-20 2021-09-02 Levo Therapeutics, Inc. Stable intranasal formulations of carbetocin
AU2019345313A1 (en) 2018-09-20 2021-03-18 Levo Therapeutics, Inc. Carbetocin drug product and process for preparing same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
US6001643A (en) * 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
AU2003257536A1 (en) * 2002-08-27 2004-03-19 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein solution preparation
FR2853551B1 (fr) * 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
MXPA05012476A (es) * 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
US7579157B2 (en) 2003-07-10 2009-08-25 Hoffmann-La Roche Inc. Antibody selection method against IGF-IR
CN1953768B (zh) * 2004-02-12 2010-10-13 默克专利有限公司 抗-egfr抗体的高浓缩液体制剂
US7691379B2 (en) * 2004-04-12 2010-04-06 Medimmune, Llc Anti-IL-9 antibody formulations

Also Published As

Publication number Publication date
AU2008248780A1 (en) 2008-11-13
JP2010524479A (ja) 2010-07-22
US20080275220A1 (en) 2008-11-06
KR20090130867A (ko) 2009-12-24
EP2144629A1 (en) 2010-01-20
AU2008248780B2 (en) 2013-01-31
US7879976B2 (en) 2011-02-01
WO2008135380A1 (en) 2008-11-13
CA2685372A1 (en) 2008-11-13
IL201391A0 (en) 2010-05-31
MX2009011408A (es) 2009-11-05
KR101140483B1 (ko) 2012-07-11
CN101674847A (zh) 2010-03-17

Similar Documents

Publication Publication Date Title
BRPI0810710A2 (pt) Método para estabilização de uma proteína.
BRPI0819127A2 (pt) Método para cimentar.
BRPI0814466A2 (pt) Método.
BRPI0807756A2 (pt) Método para produzir um l-aminoácido.
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0812446A2 (pt) Métodos para aperfeiçoamento de propriedades de proteína múltiplas
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
DK3118220T3 (da) Protein
BRPI0813569A2 (pt) Método de inspeção.
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0814971A2 (pt) Proteína
BRPI0812096A2 (pt) Máquina para pegar e armazenar preendedores de trilho de uma linha férrea, e método.
BRPI0813858A2 (pt) Método para produzir peptídeo
FI20065363A0 (fi) Erotusmenetelmä
BRPI0817885A2 (pt) Método para recuperar compostos bioativos.
BRPI0812741A2 (pt) Método para separação de glóbulos
FI20065708A0 (fi) Laitteisto yksillöllisesti muotoiltujen jalkineiden suunnittelemiseksi
BRPI0917345A2 (pt) composição, e, método para produzir uma composição estabilizada.
BRPI0810416A2 (pt) Método de hidroformação
BRPI0813366A2 (pt) Método para executar uma combustão.
NL1036308A1 (nl) Lithographic method.
BRPI0815130A2 (pt) composição, e, método para fabricar uma composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]